Poster Information 

Partial List of Poster Titles

  • Aryl-Bridged Cyclic/Bicyclic Peptoids as Conformationally Constrained Macrocyclic Peptidomimetics
  • Carbazole-Linked Carbamate Derivatives as Inhibitors for the NO Production in LPS Activated Macrophages
  • Characterization of Sponge-Derived Disulfide Rich Peptides as Scaffold for Oral Drugs
  • CMDensemble℠: A Physics Driven Strategy for Predicting Peptide and Macrocycle Structure
  • Combined Biophysical Analysis of Small Molecule Fragment Binding to the Tandem Tudor Domain Containing Epigenetic Reader, UHRF1
  • Computational Design of Novel Antibiotics
  • Derivatives of Sanguinamide B: Exploring the SAR of a Novel Macrocyclic Peptide
  • Digital Dispensing for Direct Dilution: New Flexibility in Dose-Response Analyses
  • Discovery of a Pocket Full of Promise for Cancer
  • Discovery of Novel Inhibitors Targeting Influenza Endonuclease by X-Ray Crystallographic Fragment Screening
  • Discovery of Potent CRTh2 Antagonists Containing a Carboxylic Acid Isostere
  • Exploiting Solvent Effects in Drug Design and Optimization
  • Fragment and Other Screening Compound Libraries from Life Chemicals
  • Fragment Based Approaches for Lead Generation: Identification of Activators of Sa-ClpP
  • Fragment-Based Discovery and Mechanism of Inhibitors of STAT3 by NMR
  • Fragment-Based Drug Design Using Molecular Dynamics
  • Generation of Novel Ghrelin Receptor Antagonists
  • Heterocycle-Linked Alkoxyindolyl-3-Acetic Acid Analogs as Peroxisome Proliferator-Activated Receptor-γ/δ Dual Agonists
  • High-Throughput Assay for the Identification of Inhibitors of Protein:DNA Interaction
  • High-Throughput Crystallization of Cytosolic and Membrane Bound Proteins
  • HSA-Flavonoid Binding Studies Using OneStep™ SPR Technique, a New Rapid Screening Method for Biomolecular Interactions
  • Inhibition of Protein-Protein-Interactions Using AlphaScreen Technology
  • Innovative Anti-Inflammatory and Immuno-Modulatory Dendrimers: Part 1 - Structure Optimization
  • Innovative Anti-Inflammatory and Immuno-Modulatory Dendrimers: Part 2 - Proof of Concept in Experimental Arthritis
  • Jak Inhibitors Exhibit Potent and Selective Inhibition of HIV-1 Replication in Primary Human and Rhesus Macaque Macrophages and Lymphocytes
  • Life Chemicals Specialty Targeted Libraries
  • Make Decisions Earlier in FBLD with Affinities from Primary Screening - Screening the Utility of diSPR™ in Fragment Based Drug Discovery: A Case Study
  • MapEng™, a New Platform to Aid in the Structural Analysis and Engineering of Biobetter Therapeutics
  • New MDM2-P53 Protein-Protein Interaction Inhibitors
  • New Tools for the Rapid Evaluation of Fragment Based Drug Discovery Campaigns by SPR
  • NMR-Based Screening of Ro3 Violators Selected as SaClpP Activators
  • Novel Lipid / Membrane Protein Application Kits for Label-Free Biomolecular Interaction Analysis
  • Nuphar Lutea Thioalkaloids Inhibit the NF-kB Pathway, Are Anti-Inflammatory, and Have Anti-Metastatic Activity
  • OneStep™ Fragment Screening Methods Applied to HSP90
  • Protein-Protein Interactions and Fragment Based Screening: Challenges in Hit Validation Using a Plethora of Biophysical Approaches
  • scanKINETIC: A Broadly Applicable Tool for the Kinetic Characterization of Interactions Between Small Molecule Inhibitors and Protein Targets from the Kinase and Bromodomain Families
  • Small Molecules Inhibit the Interaction of Nrf2 and the Keap1 Kelch Domain Through a Non-Covalent Mechanism
  • Structural Studies of the Active Form of Plasmodium falciparum Calpain by Homology Modeling and Covalent Docking
  • Structure of the BRAF:MEK1 Complex − How Different BRAF Inhibitors May Have Distinct Effects on Cell Fate Depending on the Conformation They Induce
  • Structure-Based Drug Design for Anti-Obesity Drug Development: Application to MC4R
  • Synthesis and Screening of Novel Conformationally Constrained Oligomers
  • Synthesis, Molecular Modeling Study, Preliminary Antibacterial and Antitumor Evaluation of N-Substituted Naphthalimides and Their Structural Analogues
  • Tackling Protein-Protein Interactions: The 2P2I Approach
  • Two-Component Covalent Inhibitors (TCCIs)

 PRESENT A POSTER AND SAVE $50! 

Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by
March 15, 2013. 

Register online, or by phone, fax or mail.  Please indicate that you would like to present a poster.  Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool.  Please see below for more information. 

Reasons you should present your research poster at this conference: 

  • Your poster will be exposed to our international delegation 
  • Receive $50 off your registration 
  • Your poster abstract will be published in our conference materials 
  • Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutes 


Note: Posters should be portrait orientation, with maximum dimensions of
36 inches wide (3 feet) x 48 inches high (4 feet). 


Click here for poster instructions